Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues

Clinical Breast Cancer

Volumn 13, Issue 2, 2013, Pages 109-118

  Ghosh, Subrata K ^a   Pantazopoulos, Pamela ^a   Medarova, Zdravka ^a   Moore, Anna ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer biomarker; Glucosylation; Malignant transformation; Sialation; Tumor grade

Indexed keywords

MUCIN 1; UNCLASSIFIED DRUG; UNDERGLYCOSYLATED MUCIN 1 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN PROCESSING; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIALYLATION; TISSUE MICROARRAY; UPREGULATION;

EID: 84875204974     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2012.09.016     Document Type: Article

References (62)

1. S. Zotter, P. Hageman, A. Lossnitzer Tissue and tumour distribution of human polymorphic epithelial mucin Cancer Res 11-12 1988 55 101
2. S. Patton, S.J. Gendler, A.P. Spicer The epithelial mucin, MUC1, of milk, mammary gland and other tissues Biochim Biophys Acta 1241 1995 407 423
3. S.J. Gendler MUC1, the renaissance molecule J Mammary Gland Biol Neoplasia 6 2001 339 353
4. M. Brayman, A. Thathiah, D.D. Carson MUC1: a multifunctional cell surface component of reproductive tissue epithelia Reprod Biol Endocrinol 2 2004 4
5. J. Wesseling, S.W. van der Valk, H.L. Vos Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components J Cell Biol 129 1995 255 265
6. J. Wesseling, S.W. van der Valk, J. Hilkens A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1 Mol Biol Cell 7 1996 565 577
7. K.G. Kohlgraf, A.J. Gawron, M. Higashi Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line Cancer Res 63 2003 5011 5020
8. L. Perey, D.F. Hayes, D. Kufe Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope Cancer Res 52 1992 6365 6370
9. K.O. Lloyd, J. Burchell, V. Kudryashov Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines Demonstration of simpler and fewer glycan chains in tumor cells J Biol Chem 271 1996 33325 33334
10. C.L. Hattrup, S.J. Gendler MUC1 alters oncogenic events and transcription in human breast cancer cells Breast Cancer Res 8 2006 R37
11. D.D. Carson The cytoplasmic tail of MUC1: a very busy place Sci Signal 1 2008 e35
12. S.M. Barratt-Boyes Making the most of mucin: a novel target for tumor immunotherapy Cancer Immunol Immunother 43 1996 142 151
13. S.J. Storr, L. Royle, C.J. Chapman The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum Glycobiology 18 2008 456 462
14. R. Singh, D. Bandyopadhyay MUC1: a target molecule for cancer therapy Cancer Biol Ther 6 2007 481 486
15. D.W. Kufe Mucins in cancer: function, prognosis and therapy Nat Rev Cancer 9 2009 874 885
16. A.C. van Hof, C.F. Molthoff, Q. Davies Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose Cancer Res 56 1996 5179 5185
17. D. Avichezer, J. Taylor-Papadimitriou, R. Arnon A short synthetic peptide (DTRPAP) induces anti-mucin (MUC-1) antibody, which is reactive with human ovarian and breast cancer cells Cancer Biochem Biophys 16 1998 113 128
18. C.D. Hough, C.A. Sherman-Baust, E.S. Pizer Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer Cancer Res 60 2000 6281 6287
19. M.D. Burdick, A. Harris, C.J. Reid Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines J Biol Chem 272 1997 24198 24202
20. R. Aoki, S. Tanaka, K. Haruma MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma Dis Colon Rectum 41 1998 1262 1272
21. P.C. Willsher, P.X. Xing, C.P. Clarke Mucin 1 antigens in the serum and bronchial lavage fluid of patients with lung cancer Cancer 72 1993 2936 2942
22. A. Maeshima, A. Miyagi, T. Hirai Mucin-producing adenocarcinoma of the lung, with special reference to goblet cell type adenocarcinoma: immunohistochemical observation and Ki-ras gene mutation Pathol Int 47 1997 454 460
23. S. Zhang, H.S. Zhang, V.E. Reuter Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers Clin Cancer Res 4 1998 295 302
24. G.J. Strous, J. Dekker Mucin-type glycoproteins Crit Rev Biochem Mol Biol 27 1992 57 92
25. M. Medina, D. Vélez, J.A. Asenjo Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells Cancer Res 59 1999 1061 1070
26. H.M. Oosterkamp, L. Scheiner, M.C. Stefanova Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z) Int J Cancer 72 1997 87 94
27. J. Burton, D. Mishina, T. Cardillo Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma Clin Cancer Res 5 1999 3065s 3072s
28. S.P. Treon, J.A. Mollick, M. Urashima Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone Blood 93 1999 1287 1298
29. V.G. Dyomin, N. Palanisamy, K.O. Lloyd MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets Blood 95 2000 2666 2671
30. P. Brossart, A. Schneider, P. Dill The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes Cancer Res 61 2001 6846 6850
31. R.T. Greenlee, T. Murray, S. Bolden Cancer statistics, 2000 CA Cancer J Clin 50 2000 7 33
32. D.F. Hayes, R. Mesa-Tejada, L.D. Papsidero Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a cancer and Leukemia Group B study J Clin Oncol 9 1991 1113 1123
33. L. Perey, D.F. Hayes, D. Kufe Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope Cancer Res 52 1992 6365 6370
34. M. Nacht, A.T. Ferguson, W. Zhang Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer Cancer Res 59 1999 5464 5470
35. B. van der Vegt, M.A. de Roos, J.L. Peterse The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma Histopathology 51 2007 322 335
36. M.A. de Roos, B. van der Vegt, J.L. Peterse The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast Histopathology 51 2007 227 238
37. J. Kononen, L. Bubendorf, A. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
38. C. Kretschmer, A. Sterner-Kock, F. Siedentopf Identification of early molecular markers for breast cancer Mol Cancer 10 2011 15 26
39. N.N. Khodarev, S.P. Pitroda, M.A. Beckett MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer Cancer Res 69 2009 2833 2837
40. D. Raina, R. Ahmad, M.D. Joshi Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells Cancer Res 69 2009 5133 5141
41. A. Moore, Z. Medarova, A. Potthast In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe Cancer Res 64 2004 1821 1827
42. Z. Medarova, L. Rashkovetsky, P. Pantazopoulos Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging Cancer Res 69 2009 1182 1189
43. A.P. Spicer, G.J. Rowse, T.K. Lidner Delayed mammary tumor progression in muc-1 null mice J Biol Chem 270 1995 30093 30101
44. A. Harduin-Lepers, M.A. Recchi, P. Delannoy The year of sialyltransferases Glycobiology 1995 1994 741 758
45. A. Harduin-Lepers, R. Mollicone, P. Delannoy The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach Glycobiology 15 2005 805 817
46. J. Burchell, R. Poulsom, A. Hanby An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas Glycobiology 9 1999 1307 1311
47. S. Lin, W. Kemmner, S. Grigull Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells Exp Cell Res 276 2002 101 110
48. M.A. Recchi, M. Hebbar, L. Hornez Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer Cancer Res 58 1998 4066 4070
49. R. Sewell, M. Bäckström, M. Dalziel The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer J Biol Chem 281 2006 3586 3594
50. M.M. Fuster, J.D. Esko The sweet and sour of cancer: glycans as novel therapeutic targets Nat Rev Cancer 5 2005 526 542
51. K.J. Livak, T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method Methods 25 2001 402 408
52. H.J. Gross, U. Sticher, R. Brossmer A highly sensitive fluorometric assay for sialyltransferase activity using CMP-9-fluoresceinyl-NeuAc as donor Anal Biochem 186 1990 127 134
53. A. Cazet, S. Julien, M. Bobowski Consequences of the expression of sialylated antigens in breast cancer Carbohydr Res 345 2010 1377 1383
54. E.A. Rakha, R.W. Boyce, D. Abd El-Rehim Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer Mod Pathol 18 2005 1295 1304
55. J.J. Rahn, L. Dabbagh, M. Pasdar The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature Cancer 91 2001 1973 1982
56. J.S. Chu, K.J. Chang Mucin expression in mucinous carcinoma and other invasive carcinomas of the breast Cancer Lett 142 1999 121 127
57. T. Nishidate, T. Katagiri, M.L. Lin Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis Int J Oncol 25 2004 797 819
58. W.H. Yoon, H.D. Park, K. Lim Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells Biochem Biophys Res Commun 222 1996 694 699
59. Z. Medarova, W. Pham, Y. Kim In vivo imaging of tumor response to therapy using a dual-modality imaging strategy Int J Cancer 118 2006 2796 2802
60. M. Kumar, M. Yigit, G. Dai Image-guided breast tumor therapy using a small interfering RNA nanodrug Cancer Res 70 2010 7553 7561
61. M. Hutteman, J.S. Mieog, J.R. van der Vorst Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients Breast Cancer Res Treat 127 2011 163 170
62. D.W. Kufe MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches Oncogene May 14 2012 [Epub ahead of print]